透景生命：8月26日召开董事会会议

Group 1 - The core point of the article is that TuoJing Life (SZ 300642) held its fourth board meeting on August 26, 2025, to review the semi-annual report and related documents [1] - For the year 2024, TuoJing Life's revenue composition is entirely from the in vitro diagnostics industry, accounting for 100.0% [1]